“THE REAL OPIOID CRISIS,” DISCREDITING PROGRESS RADIO AND URBAN VIEW XM-127/XM-126, JOE SUDBAY, JOHN FUGELSANG, KAREN HUNTER, AND DEBUNKING D.E.A. PRESCRIPTION “OPIOID JUNK SCIENCE IN MEDIA”

“UNLEASH THE BEAST”

!!Finally, Someone is Listening to People in Pain!!

PART-1

“The Real Opioid Crisis in Three Charts”: a patient advocacy group has briefed senior officials of the US FDA on major changes needed in public health policy for the regulation of prescription opioid pain relievers and doctors who prescribe them. Perhaps now, someone is truly listening to people in pain.

republished from America Council on Science and Health youarewithinthenorms

NORMAN J CLEMENT RPH., DDS, NORMAN L. CLEMENT PHARM-TECH, MALACHI F. MACKANDAL PHARMD, BELINDA BROWN-PARKER, IN THE SPIRIT OF JOSEPH SOLVO ESQ., INC.T. SPIRIT OF REV. IN THE SPIRIT OF WALTER R. CLEMENT BS., MS, MBA. HARVEY JENKINS MD, PH.D., IN THE SPIRIT OF C.T. VIVIAN, JELANI ZIMBABWE CLEMENT, BS., MBA., IN THE SPIRIT OF THE HON. PATRICE LUMUMBA, IN THE SPIRIT OF ERLIN CLEMENT SR., EVELYN J. CLEMENT, WALTER F. WRENN III., MD., JULIE KILLINGSWORTH, RENEE BLARE, RPH, DR. TERENCE SASAKI, MD LESLY POMPY MD., CHRISTOPHER RUSSO, MD., NANCY SEEFELDT, WILLIE GUINYARD BS., JOSEPH WEBSTER MD., MBA, BEVERLY C. PRINCE MD., FACS., NEIL ARNAND, MD.RICHARD KAUL, MD., LEROY BAYLOR, JAY K. JOSHI MD., MBA, ADRIENNE EDMUNDSON, ESTER HYATT PH.D., WALTER L. SMITH BS., IN THE SPIRIT OF BRAHM FISHER ESQ., MICHELE ALEXANDER MD., CUDJOE WILDING BS, MARTIN NJOKU, BS., RPH., IN THE SPIRIT OF DEBRA LYNN SHEPHERD, BERES E. MUSCHETT, STRATEGIC ADVISORS

RED LAWHERN
RICHARD LAWHERN, PH.D

By Red Lawhern — Jul 30, 2024

“As an unpaid healthcare writer and patient advocate, I’ve written for 27 years on opioid prescribing, pain management, and patient advocacy

Several of my shorter articles appear on Pain News Network or here on the American Council on Science and Health.   Until recently, my work and that of many others had been met with official governmental silence (aka “stonewalling” by government authorities).”  

The silence might be about to change  

Finally, Someone is Listening to People in Pain!

FDA
FDA is “responsible for protecting the public health by ensuring the safety, efficacy, and security of . . . medical devices . . .”74 A “device” subject to FDA regulation includes “an instrument . . . , machine . . . , or other similar or related article . . . which is . . . intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease . . .”

On July 23, 2024, I joined six other members of the Speakers Bureau of the National Campaign to Protect People in Pain to offer a one-hour “listening session” to senior officials of the US FDA Center for Drug Evaluation and Research (CDER). 

A 25-page summary of the proceedings has been posted to social media platforms and shared with the US FDA Office of Communications, Professional Affairs and Stakeholder Engagement (PASE).  Under the session rules, what follows below does not represent a commitment by the FDA either to validate our stated findings or to take action thereon.

The one-hour FDA presentation was titled “The Real Opioid Crisis in Three Charts.” Our key points included these:

  • If the FDA audience carries away nothing else from this session, they should remember this:  There is no such thing as opioid use disorder. The term originated in 2013 with the 5th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) – a document rejected by the National Institute for Mental Health as a framework for organizing research.   Data published by the CDC itself completely discredits the notion that doctors prescribing to their patients are or ever were responsible for the US opioid crisis.  Both the CDC and DEA have known this reality for years.
  • US CDC and US DEA are usurping missions delegated to the FDA by law in the establishment of safety standards for prescription drugs. The consequence of this usurpation is the ongoing destruction of American pain medicine.
  • CDC prescribing guidelines can be shown to incorporate outright fraud, including failure to address genetically mediated opioid metabolism, misrepresentation of the effectiveness of non-opioid alternative therapies, one-size-fits-all MMED dose criteria unsupported by science, and misrepresentation of opioid therapy, especially high-dose opioid therapy, as ineffective for long-term use.
  • DEA prosecutions are grounded on non-representative “expert witnesses” who testify to anything DEA wants, no matter how false.  Likewise, Administrative Law  Judges deny defendants adequate representation by pre-trial asset confiscationsand by rulings biased in favor of the DEA.
  • It is now known beyond contradiction that the incidence of addiction and overdose in pain patients treated by a doctor is too small to measure accurately within confounds of diagnosis and poor clinician training. Law enforcement is particularly ill-equipped to comment on this issue.  It is also known to the CDC and DEA that doctors overprescribing to patients was never a significant cause of the US opioid crisis — and is not now.
  • Our speakers appealed to the FDA to take public action to repudiate and demand the withdrawal of horrendously damaging injunctive relief provisions imposed by the National Opioid Settlement.  We also encouraged the Agency to take immediate action to correct its own databases concerning shortages of prescription opioids created by the US National Opioid Settlement injunction.
  • We asked FDA to publicly repudiate and demand withdrawal of CDC/VA/DoD opioid prescribing guidelines, without replacement.  In a spirit of transparency, we also disclosed that stakeholder participants in the session are co-complainants in formal complaint actions filed May 21, 2024 with the US Department of Justice Office of Civil Rights and the Office of the Inspector General of DHHS. We allege criminal fraud and denial of US citizens’ civil rights on the part of CDC authors and approving officials for the 2016 and 2022 published opioid prescribing guidelines. 
HELEN BOREL RN EXPOSE INJUSTICE

Findings briefed in the FDA Listening Session are being disseminated widely to US government Agencies, including the National Institutes of Health, the National Institute on Drug Abuse, the National Centers for Injury Prevention and Control, and the Offices of the Surgeon General and the Inspector General in the Department of Health and Human Services.

This is the horrible truth: the US Government is all-powerful and can destroy everyone and everything, and its agents, the US prosecutors, are under orders to reduce the entire population of “the land of the free” to serfdom.  And they can do it, and they will do it.  They did it to me.  They’ve done it to TENS OF THOUSANDS of decent people, including Dr. Shiva Akula, Nova Montgomery, and more than we could ever name in four days running. 
This is an OUTRAGE.  This prosecutor’s report on policy makes a MOCKERY of the Constitution and the whole concept of “Truth, Justice, and the American Way”—because prosecutors with this “TOOLBOX” he talks about—can put EVERYONE in jail FOREVER if they want to.  It makes me sick.

Online meetings are being requested with the Federation of State Medical Boards and all State Medical Boards, Boards of Pharmacy, and Departments of Health. 
It is time for the war on chronic pain patients, doctors, and pharmacists to end.  This Listening Session may be a first step in finally getting government authorities to hear our urgent pleas.

GENERAL SESSION FORMER US AG JEFFEREY BOLEGARD SESSION

FOR NOW, YOU ARE WITHIN

THE NORMS

reference:

THE POWER OF PROGRESSIVE IGNORANCE

1.

@thekatinthehatz

#question from @thekatinthehatz Please answer with comments or mesages—my reps have said collecting our stories is the most powerful form of persuasion—it worked for me. ❤️@American Pain & Disability FDN @Bob Sheerin @annsmith7707 @brandonpollard435 @AnnemarieUSA @DoraWinterz #CPP #CDCGuidelines #SavingUsToDeath #PainVisibility #ChronicPain

♬ Everybody Hurts – Instrumental – Guitar Dreamers

2.

Richard A. Lawhern, PhD is a volunteer subject matter expert on public health policy for the regulation of prescription opioid analgesics and clinicians who employ them. Over 27 years, he has authored or co-authored over 250 papers, articles, and interviews in a mixture of peer-reviewed medical journals and mass media. He is also a member of the Scientific Advisory Board of ACSH,

The National Campaign to Protect People in Pain is an informal alliance of hundreds of experienced pain management clinicians, patients, family caregivers, and advocates.  The National Campaign is lobbying for major changes in public health policy governing the practice of pain medicine in America.     

Leave a Reply